Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3456

Enzyme Inhibitors Market by Type (Proton Pump Inhibitors [PPIs], Protease Inhibitors, Reverse Transcriptase Inhibitors, Aromatase Inhibitors, Kinase Inhibitors, Neuraminidase Inhibitors, Statins, and Others) and by Application (Chemotherapy, Antibiotics, Pesticides, Cardiovascular Treatments, and Others) - Global Opportunity Analysis & Industry Forecast, 2017-2023

LI_181880
Pages: NA
Jun 2018 | 1185 Views
face gplus_n
Author's : NA
Tables: NA
Charts: NA
twit_n pr_n

Enzyme inhibitors are naturally occurring molecules that attach to the enzymes to inhibit the culture of harmful pathogens and enhance metabolism. They have varied applications as drugs in therapeutics and pesticides for agricultural activities. In recent years, the market has witnessed significant growth owing to outsourcing manufacturing process coupled with effective & accurate therapies for chronic diseases such as cancer, respiratory diseases, and others.

This report projects the global enzyme inhibitors market with trends, opportunities, and its demand by 2022. This research includes qualitative & quantitative analyses with comprehensive research methodologies and reliable forecasts to create the present overview of the market and predict the market during the forecast period. Our research teams have used various secondary resources & directories such as industrial databases, journals & magazine, along with primary resources, coupled with industry-oriented measures, such as industry-related expert interviews, to obtain key information and valuables.

Inactive lifestyle, unhealthy dietary plans, and excessive alcohol consumption and smoking have resulted in a significant rise in diseases such as inflammatory lungs, cancer, hypertension & respiratory infections. These factors have paved the way for the market to grow, with effective treatments and reduced infection rates. Proton pump inhibitors registered notable growth owing to increase in gastroesophageal reflux treatments followed by protease inhibitors in HIV medications. Kinase & aromatic inhibitors are expected to witness lucrative growth owing to their application in cancerous cells. Europe has dominated the enzyme inhibitors market, supplemented with developments in healthcare and investment in R&D. Asia-Pacific followed by LAMEA are estimated to be potential market drivers owing to increase in pharmaceutical establishments and agricultural activities. Patent expirations of enzyme inhibitors and low-cost generics adversely affect the revenue generation; however, development of healthcare infrastructure and novel inhibitors is expected to provide a significant boost to market growth.

The enzyme inhibitors market is segmented based on type, application, and geography. Based on type, it includes proton pumps inhibitors (PPIs), protease inhibitors, reverse transcriptase inhibitors, aromatase inhibitors, kinase inhibitors, neuraminidase inhibitors, statins, and others. According to application, it is categorized into chemotherapy, antibiotics, pesticides, cardiovascular treatments, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key players operating in this market include AstraZeneca, GlaxoSmithKline, Bayer, Novartis, Roche & Pfizer, Ranbaxy Laboratories, Johnson & Johnson, Abbott Laboratories Inc., and Takeda.

KEY BENEFITS FOR STAKEHOLDERS:

  • This report provides a quantitative analysis of the current trends, future estimations, clinical developments, and dynamics through 20142022, which assist in identifying the market behavior and prevailing opportunities.
  • Major countries in each region are mapped as per individual market revenue.
  • This study takes into account the competitive landscape and value chain to understand the competitive environment across the geographies.
  • Comprehensive analysis of factors that drive and restrict the growth of the enzyme inhibitors market is provided.
  • Leading players and their key developments in recent years are listed.

KEY MARKET SEGMENTS:

By Type

  • Proton Pump Inhibitors (PPIs)
  • Protease Inhibitors
  • Reverse Transcriptase Inhibitors
  • Aromatase Inhibitors
  • Kinase Inhibitors
  • Neuraminidase Inhibitors
  • Statins
  • Others

By Application

  • Chemotherapy
  • Antibiotics
  • Pesticides
  • Cardiovascular Treatments
  • Others.

By Geography

  • North America
    • U.S.
    • Canada
    • Others
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Middle East
    • South Africa
    • Rest of LAMEA
 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Purchase Full Report of
Enzyme Inhibitors Market- Global Opportunity Analysis & Industry Forecast, 2014-2022

  • Online Only
  • $3456
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts